Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy

BMJ Case Reports

Volumn , Issue , 2009, Pages

  Cusini, Alexia ^a   Günthard, Huldrych F ^a   Weber, Rainer ^a   Huber, Milo ^a   Kamarashev, Jivko ^a   Bertisch, Barbara ^a   Peter, Silke ^b   Beck, Bernhard ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897585553     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.05.2009.1904     Document Type: Article

References (35)

1. Lawn SD, Wood C, Lockwood DN. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis 2003; 36: e5-6. [Abstract/FREE Full text]
2. Pereira GA, Stefani MM, Araújo Filho JA, et al. Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort. Am J Trop Med Hyg 2004; 71: 679-84. [Abstract/FREE Full text] (Pubitemid 39601171)
3. Pignataro P, Rocha Ada S, Nery JA, et al. Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2004; 23: 408-11. [CrossRef] [Medline] [Web of Science] (Pubitemid 38797726)
4. Couppie P, Abel S, Voinchet H, et al. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol 2004; 140: 997-1000. [CrossRef] [Medline] [Web of Science] (Pubitemid 39062652)
5. Visco-Comandini U, Longo B, Cuzzi T, et al. Tuberculoid leprosy in a patient with AIDS: a manifestation of immune restoration syndrome. Scand J Infect Dis 2004; 36: 881-3. [CrossRef] [Medline] [Web of Science] (Pubitemid 40074027)
6. Narang T, Dogra S, Kaur I. Borderline tuberculoid leprosy with type 1 reaction in an HIV patient - a phenomenon of immune reconstitution. Int J Lepr Other Mycobact Dis 2005; 73: 203-5. [Medline] [Web of Science]
7. Singal A, Mehta S, Pandhi D. Immune reconstitution inflammatory syndrome in an HIV seropositive leprosy patient. Lepr Rev 2006; 77: 76-80. [Medline] [Web of Science]
8. Kharkar V, Bhor UH, Mahajan S, et al. Type I lepra reaction presenting as immune reconstitution inflammatory syndrome. Indian J Dermatol Venereol Leprol 2007; 73: 253-6. [CrossRef] [Medline] [Web of Science] (Pubitemid 47219996)
9. Talhari C, Machado PRL, Ferreira LC, et al. Shifting of the clinical spectrum of leprosy in an HIV-positive patient: a manifestation of immune reconstitution inflammatory syndrome? Lepr Rev 2007; 78: 151-4. [Medline] [Web of Science] (Pubitemid 47451140)
10. Batista MD, Porro AM, Maeda SM, et al. Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS. Clin Infect Dis 2008; 46: e56-60. [Abstract/FREE Full text] (Pubitemid 351417216)
11. Deps PD, Gripp CG, Madureira BP, et al. Immune reconstitution syndrome associated with leprosy: two cases. Int J STD AIDS 2008; 19: 135-6. [Abstract/FREE Full text] (Pubitemid 351738826)
12. Menezes VM, Sales AM, Illarramendi X, et al. Leprosy reaction as a manifestation of immune reconstitution inflammatory syndrome: a case series of a Brazilian cohort. AIDS 2009; 23: 641-3. [CrossRef] [Medline] [Web of Science]
13. Peter-Getzlaff S, Lüthy J, Böddinghaus B, et al. Development and evaluation of a molecular assay for detection of nontuberculous mycobacteria by use of the COBAS Amplicor platform. J Clin Microbiol 2008; 46: 4023-8. [Abstract/FREE Full text]
14. World Health Organization. Guide to eliminate leprosy as a public health problem. Geneva: WHO, 2000.
15. Villahermosa LG, Fajardo TT Jr, Abalos RM, et al. Parallel assessment of 24 monthly doses of rifampin, of loxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy. Am J Trop Med Hyg 2004; 70: 197-200. [Abstract/FREE Full text] (Pubitemid 38200526)
16. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133: 447-54. [Medline] [Web of Science]
17. Shelburne SA 3rd, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev 2003; 5: 67-79. [Medline]
18. Periche Fernandez J, Isa Isa R, Canario Lopez S, et al. Erythema nodosum leprosum as immune reconstitution inflammatory syndrom in a HIV infected person. Int Lepr Congr 2008 (abstr.); 71. Search Google Scholar
19. Deps PD, Lockwood DN. Leprosy occurring as immune reconstitution syndrome. Trans R Soc Trop Med Hyg 2008; 102: 966-8. [Abstract/FREE Full text]
20. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002; 81: 213-27. [CrossRef] [Medline] [Web of Science] (Pubitemid 34507208)
21. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005; 19: 399-406. [CrossRef] [Medline] [Web of Science] (Pubitemid 40446186)
22. Kumar B, Dogra S, Kaur I. Epidemiological characteristics of leprosy reactions: 15 years experience from north India. Int J Lepr Other Mycobact Dis 2004; 72: 125-33. [CrossRef] [Medline] [Web of Science] (Pubitemid 39006885)
23. Yawalkar SJ. Leprosy for medical practitioners and paramedical workers. Basle: Novartis Foundation for Sustainable Development, 2002. Search Google Scholar
24. Kahawita IP, Lockwood DN. Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg 2008; 102: 329-37. [Abstract/FREE Full text]
25. Modlin RL, Gebhard JF, Taylor CR, et al. In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Clin Exp Immunol 1983; 53: 17-24. [Medline] [Web of Science] (Pubitemid 13106746)
26. Modlin RL, Bakke AC, Vaccaro SA, et al. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum. Arch Dermatol 1985; 121: 216-19. [CrossRef] [Medline] [Web of Science]
27. Modlin RL, Mehra V, Jordan R, et al. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum. J Immunol 1986; 136: 883-6. [Abstract] (Pubitemid 16146370)
28. Narayanan RB, Laal S, Sharma AK, et al. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy. Clin Exp Immunol 1984; 55: 623-8. [Medline] [Web of Science] (Pubitemid 14185822)
29. Rao TD, Rao PR. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy. Indian J Lepr 1986; 58: 601-8. [Medline] (Pubitemid 17046595)
30. Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis 2006; 6: 350-60. [CrossRef] [Medline] [Web of Science] (Pubitemid 43737271)
31. Saunderson P, Gebre S, Byass P. ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors. Lepr Rev 2000; 71: 318-24. [Medline] [Web of Science]
32. Nery JA, Vieira LM, de Matos HJ, et al. Reactional states in multibacillary Hansen disease patients during multidrug therapy. Rev Inst Med Trop Sao Paulo 1998; 40: 363-70. [Medline] (Pubitemid 128472813)
33. Pocaterra L, Jain S, Reddy R, et al. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg 2006; 74: 868-79. [Abstract/FREE Full text] (Pubitemid 46774411)
34. Schreuder PA. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study. Int J Lepr Other Mycobact Dis 1998; 66: 149-58. [Medline] [Web of Science]
35. de Messias IJ, Santamaria J, Brenden M, et al. Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy. Clin Exp Immunol 1993; 92: 284-7. [Medline] [Web of Science] (Pubitemid 23151039)